COMMUNIQUÉS West-GlobeNewswire

-
Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer
10/12/2018 -
Catalyst Biosciences to Host a Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs
10/12/2018 -
Molina Healthcare Selects Inovalon to Provide Data-Driven Insights to Improve Member Care
10/12/2018 -
CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors
10/12/2018 -
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
10/12/2018 -
Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel
10/12/2018 -
Novan Announces Full Top Line Results from Phase 2 Molluscum Contagiosum Clinical Trial and Decision to Move Forward with SB206 12% Once-Daily
10/12/2018 -
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
10/12/2018 -
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
10/12/2018 -
Apotheca Biosciences (PCFP) Announces the Roll Out of Apotheca Earth, Direct to Business & Consumer Medical Grade CBD Products - Apotheca Earth to Begin National Sales & Marketing Campaign
10/12/2018 -
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
10/12/2018 -
IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018
10/12/2018 -
Resonant Inc. Launches Filter IP Standard Library; Leading Power Amplifier Vendor Licenses First Fast-Track Quadplexer Solution from the Library
10/12/2018 -
ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10
10/12/2018 -
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder
10/12/2018 -
Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
10/12/2018 -
Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead
10/12/2018 -
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, December 12, 2018
10/12/2018 -
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology
10/12/2018
Pages